Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peri-operative Chemotherapy in High-risk Localized Soft Tissue Sarcoma
NCT04307277Phase 3Recruiting
- Sponsor
- Institut Claudius Regaud
- Start
- Oct 2020
- Primary completion
- Oct 2032
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of pegylated liposomal doxorubicin in soft tissue sarcoma (STS), sponsored by Institut Claudius Regaud. Started Oct 2020; status: recruiting.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT04307277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04307277.